Defining a TCF1-expressing progenitor allogeneic CD8<sup>+</sup> T cell subset in acute graft-versus-host disease.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37737221.
- Also identified by DOI 10.1038/s41467-023-41357-9 and PMC identifier 10516895.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Graft-versus-host disease (GvHD) is a severe complication of hematopoietic stem cell transplantation driven by activated allogeneic T cells. Here, we identify a distinct subset of T cell factor-1 (TCF1)<sup>+</sup> CD8<sup>+</sup> T cells in mouse allogeneic and xenogeneic transplant models of acute GvHD. These TCF1<sup>+</sup> cells exhibit distinct characteristics compared to TCF1<sup>-</sup> cells, including lower expression of inhibitory receptors and higher expression of costimulatory molecules. Notably, the TCF1<sup>+</sup> subset displays exclusive proliferative potential and could differentiate into TCF1<sup>-</sup> effector cells upon antigenic stimulation. Pathway analyses support the role of TCF1<sup>+</sup> and TCF1<sup>-</sup> subsets as resource cells and effector cells, respectively. Furthermore, the TCF1<sup>+</sup> CD8<sup>+</sup> T cell subset is primarily present in the spleen and exhibits a resident phenotype. These findings provide insight into the differentiation of allogeneic and xenogeneic CD8<sup>+</sup> T cells and have implications for the development of immunotherapeutic strategies targeting acute GvHD.
Medical subject headings
- Graft vs Host Disease
- Hematopoietic Stem Cell Transplantation